ERBB2 and breast carcinoma: For example, interstitial fluid flow induced invasion of HER2-expressing breast cancer cells [10], potentiated mobility in metastatic esophageal cancer cells [11], regulated invasiveness in glioma cells [11, 12], and modulated receptor-mediated apoptosis in lung cancer cells [13].